Read + Share
Amedeo Smart
Independent Medical Education
Law JLM, Logan M, Joyce MA, Landi A, et al. SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Vaccine 2021;39:5769-5779.PMID: 34481699
Email
LinkedIn
Facebook
Twitter
Privacy Policy